Back to Search
Start Over
Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment-induced clearance
- Source :
- Journal of medical virology. 90(12)
- Publication Year :
- 2018
-
Abstract
- Background and aim To observe the clinical value of hepatitis C virus (HCV) core antigen (HCcAg) levels in monitoring acute HCV infection in patients with spontaneous clearance (SC) or clearance induced by antiviral therapy. Methods Patients with iatrogenic HCV infection (n = 104) were enrolled at the Shengjing Hospital, China Medical University, between 5 February 2013 and 3 April 2013. All cases were diagnosed with acute HCV infection, enrolled within 90 days of infection, and followed for 12 to 16 weeks. Blood was collected every month. HCV RNA and HCcAg levels were detected. From week 16, patients without SC were treated with pegylated-interferon and the HCV RNA and HCcAg levels were observed monthly. Follow-up was 7.5 (5.0 to 10.4) months. The Spearman correlation analysis was performed to determine the correlation between HCV RNA and HCcAg. Logistic regression analysis was used to determine the association of baseline HCV RNA and HCcAg levels with SC. Results Ten patients (9.62%) showed SC, with a negative conversion time of 57 (14 to 143) days. During follow-up, HCV RNA and HCcAg expression levels were positively correlated for each patient (except on the sixth month), but the levels of HCV RNA and HCcAg were not associated with HCV infection SC. Conclusions HCcAg levels could be of value for monitoring the course early HCV infection, but could not predict SC of HCV infection.
- Subjects :
- 0301 basic medicine
Adult
Male
medicine.medical_specialty
China
Hepatitis C virus
Remission, Spontaneous
medicine.disease_cause
Gastroenterology
Antiviral Agents
Hospitals, University
03 medical and health sciences
0302 clinical medicine
Antigen
Virology
Internal medicine
Hepatitis C virus RNA
medicine
Humans
In patient
Aged
business.industry
Antiviral therapy
virus diseases
Middle Aged
Hepatitis B Core Antigens
Hepatitis C
digestive system diseases
030104 developmental biology
Infectious Diseases
Treatment Outcome
Clinical value
RNA, Viral
030211 gastroenterology & hepatology
Female
Hepatitis C virus core Antigen
Acute hepatitis C
Drug Monitoring
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 10969071
- Volume :
- 90
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Journal of medical virology
- Accession number :
- edsair.doi.dedup.....a9829c380b0d8eec21e478e02d2d8bc0